Corcept Therapeutics Incorporated (CORT) — Free Cash Flow Generation Index
Corcept Therapeutics Incorporated (CORT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $38.40 Million represents 1% of operating cash flow ($38.45 Million). Read total liabilities of Corcept Therapeutics Incorporated for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Corcept Therapeutics Incorporated across 11 annual periods. Explore CORT capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Free Cash Flow Generation Index for Corcept Therapeutics Incorporated. For the full company profile including market capitalisation, see market cap of Corcept Therapeutics Incorporated.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $141.78 Million | $142.00 Million | $211.00K | ▲ +1.0% |
| 2024 | 0.99x | $195.90 Million | $198.07 Million | $2.17 Million | ▼ -1.0% |
| 2023 | 1.00x | $126.90 Million | $127.04 Million | $139.00K | ▲ +0.2% |
| 2022 | 1.00x | $119.91 Million | $120.32 Million | $413.00K | ▼ -0.1% |
| 2021 | 1.00x | $167.42 Million | $167.89 Million | $469.00K | ▲ +0.5% |
| 2020 | 0.99x | $150.73 Million | $151.97 Million | $1.24 Million | ▼ 0.0% |
| 2019 | 0.99x | $135.03 Million | $136.12 Million | $1.09 Million | ▼ -0.5% |
| 2018 | 1.00x | $115.37 Million | $115.67 Million | $298.00K | ▲ +0.4% |
| 2017 | 0.99x | $60.52 Million | $60.94 Million | $419.00K | ▲ +0.4% |
| 2016 | 0.99x | $18.20 Million | $18.39 Million | $194.00K | ▼ -0.5% |
| 2015 | 0.99x | $3.11 Million | $3.13 Million | $17.00K | — |